![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Studies zoom in on clues to why Lyme disease persists and which antibiotic to prescribe
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be more effective.
It starts with the ticks. These insects infect people with the bacteria that cause Lyme disease, microbes that are complicated to study, difficult to detect when they cause illness, and challenging to treat so they don’t linger in the human body.
Understanding that bacterium, Borrelia burgdorferi, requires basic research before creating diagnostics or vaccines, slow progress that is frustrating for people affected by the chronic fatigue and brain fog of long-term Lyme disease or the joint pain of Lyme arthritis.
